Ascletis Pharma Inc. (1672.HK)

HKD 6.25

(8.32%)

Long Term Debt Summary of Ascletis Pharma Inc.

Ascletis Pharma Inc.'s latest annual long term debt in 2023 was 2.7 Million CNY , up 48.6% from previous year.
Ascletis Pharma Inc.'s latest quarterly long term debt in 2024 Q2 was - CNY , down 0.0% from previous quarter.
Ascletis Pharma Inc. reported annual long term debt of 1.82 Million CNY in 2022, up 54.06% from previous year.
Ascletis Pharma Inc. reported annual long term debt of 1.18 Million CNY in 2021, up 166.82% from previous year.
Ascletis Pharma Inc. reported quarterly long term debt of - CNY for 2024 Q1, down 0.0% from previous quarter.
Ascletis Pharma Inc. reported quarterly long term debt of 1.16 Million CNY for 2023 Q1, down -35.86% from previous quarter.

Annual Long Term Debt Chart of Ascletis Pharma Inc. (2023 - 2016)

Historical Annual Long Term Debt of Ascletis Pharma Inc. (2023 - 2016)

Year	Long Term Debt	Long Term Debt Growth
2023	2.7 Million CNY	48.6%
2022	1.82 Million CNY	54.06%
2021	1.18 Million CNY	166.82%
2020	443 Thousand CNY	-72.09%
2019	1.58 Million CNY	0.0%
2018	- CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- CNY	0.0%
2024 Q1	- CNY	0.0%
2023 Q1	1.16 Million CNY	-35.86%
2023 FY	2.7 Million CNY	48.6%
2023 Q4	2.7 Million CNY	0.0%
2023 Q3	2.7 Million CNY	131.68%
2023 Q2	1.16 Million CNY	0.0%
2022 Q3	1.82 Million CNY	204.52%
2022 Q2	598 Thousand CNY	0.0%
2022 Q1	598 Thousand CNY	-49.41%
2022 Q4	1.82 Million CNY	0.0%
2022 FY	1.82 Million CNY	54.06%
2021 FY	1.18 Million CNY	166.82%
2021 Q3	1.18 Million CNY	-32.42%
2021 Q4	1.18 Million CNY	0.0%
2021 Q1	1.74 Million CNY	294.81%
2021 Q2	1.74 Million CNY	0.0%
2020 Q2	1.02 Million CNY	0.0%
2020 Q3	443 Thousand CNY	-56.65%
2020 Q4	443 Thousand CNY	0.0%
2020 Q1	1.02 Million CNY	-35.6%
2020 FY	443 Thousand CNY	-72.09%
2019 Q1	3.52 Million CNY	0.0%
2019 FY	1.58 Million CNY	0.0%
2019 Q4	1.58 Million CNY	0.0%
2019 Q3	1.58 Million CNY	-54.97%
2019 Q2	3.52 Million CNY	0.0%
2018 Q1	- CNY	0.0%
2018 FY	- CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q3	- CNY	0.0%
2018 Q2	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q1	- CNY	0.0%
2017 Q3	- CNY	0.0%
2017 Q4	- CNY	0.0%
2016 FY	- CNY	0.0%

Peer Long Term Debt Comparison of Ascletis Pharma Inc.

Name	Long Term Debt	Long Term Debt Difference
Uni-Bio Science Group Limited	30.61 Million HKD	91.16%
CK Life Sciences Int'l., (Holdings) Inc.	4.27 Billion HKD	99.937%